Prostatis Group’s Mastercard MA Stock Holding History

Prostatis Group’s Portfolio MA Stock Details MA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-11,012	Closed	-$11K	–	181
2023 Q2	$11K	Buy	+11,012	New	+$4.13M	0.01%	247

Other funds holding MA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Prostatis Group's MA Position: Q3 2023 in Review

Prostatis Group sold out of Mastercard (MA) in Q3 2023, closing a stake of 11,012 shares — an estimated $11K sold.

Prostatis Group first reported a position in MA in Q2 2023 and held it in 1 quarter. The position peaked at $11K in Q2 2023. 2,815 funds tracked by Wall St. Rank hold MA as of Q3 2023.

Prostatis Group reported no remaining Mastercard position as of Q3 2023 after selling out during the quarter.
Prostatis Group sold 11,012 Mastercard shares in Q3 2023, an estimated $11K.
Prostatis Group first reported a position in Mastercard in Q2 2023 and held it in 1 quarter.
Prostatis Group's Mastercard position peaked at $11K in Q2 2023.
2,815 funds tracked by Wall St. Rank held Mastercard as of Q3 2023.

Based on Prostatis Group's 13F filing for Q3 2023, filed 21 Mar 2025.